STEPHANIE BOHLAND-FANFULIK: Open Payments
NPI 1205521176 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 81 payments from 14 companies in 2025. Trend: 2023 $406 · 2024 $1,199 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $367 |
| Janssen Biotech, Inc. | 11 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $148 |
| PFIZER INC. | 6 | $148 |
| Madrigal Pharmaceuticals | 5 | $87 |
| Lilly USA, LLC | 3 | $76 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
| Ferring Pharmaceuticals Inc. | 2 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, RINVOQ, SKYRIZI, XELJANZ, REZDIFFRA, OMVOH.
Industry payments across OH — which companies pay providers there.
